DARBEPOETIN ALFA for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 29 adverse event reports in the FDA FAERS database where DARBEPOETIN ALFA was used for Off label use.
Most Reported Side Effects for DARBEPOETIN ALFA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 12,264 | 37.4% | 12,260 | 2,158 |
| Hospitalisation | 5,682 | 17.3% | 1,161 | 5,657 |
| Product storage error | 1,619 | 4.9% | 3 | 28 |
| Off label use | 1,586 | 4.8% | 364 | 446 |
| Circumstance or information capable of leading to medication error | 1,050 | 3.2% | 0 | 5 |
| Haemodialysis | 907 | 2.8% | 53 | 464 |
| Pneumonia | 733 | 2.2% | 235 | 630 |
| Fall | 726 | 2.2% | 125 | 648 |
| Anaemia | 562 | 1.7% | 162 | 390 |
| Dialysis | 555 | 1.7% | 37 | 191 |
| Haemoglobin decreased | 546 | 1.7% | 47 | 284 |
| Malaise | 529 | 1.6% | 113 | 397 |
| Sepsis | 510 | 1.6% | 371 | 336 |
| Dyspnoea | 425 | 1.3% | 144 | 328 |
| Renal disorder | 416 | 1.3% | 67 | 340 |
Other Indications for DARBEPOETIN ALFA
Product used for unknown indication (21,427)
Nephrogenic anaemia (5,332)
Anaemia (2,096)
Chronic kidney disease (1,293)
Myelodysplastic syndrome (1,164)
Anaemia of malignant disease (155)
Renal disorder (152)
Renal failure (128)
End stage renal disease (64)
Renal transplant (53)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)